Jackson Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
BPC
Jackson Wealth Management's MRNA Position: Q1 2021 in Review
Jackson Wealth Management sold out of Moderna (MRNA) in Q1 2021, closing a stake of 3,010 shares — an estimated $314K sold.
Jackson Wealth Management first reported a position in MRNA in Q3 2020 and held it in 2 quarters. The position peaked at $314K in Q4 2020. 776 funds tracked by Wall St. Rank hold MRNA as of Q1 2021.
- Jackson Wealth Management reported no remaining Moderna position as of Q1 2021 after selling out during the quarter.
- Jackson Wealth Management sold 3,010 Moderna shares in Q1 2021, an estimated $314K.
- Jackson Wealth Management first reported a position in Moderna in Q3 2020 and held it in 2 quarters.
- Jackson Wealth Management's Moderna position peaked at $314K in Q4 2020.
- 776 funds tracked by Wall St. Rank held Moderna as of Q1 2021.
Based on Jackson Wealth Management's 13F filing for Q1 2021, filed 12 Apr 2021.